Keyphrases
Adverse Drug Reaction
100%
Off-label Use
62%
Spontaneous Reporting
41%
Pharmacovigilance
36%
Patient Register
35%
Rituximab
35%
Neurotoxic Effects
31%
Ertapenem
31%
Acute Confusional State
31%
Educational Session
31%
Outpatient Treatment
31%
Multicentric
31%
Severe Disease
31%
Hospital Outpatient Clinics
31%
Disease Activity
31%
Systemic Lupus Erythematosus
31%
Extrarenal
31%
Creatinine Clearance
23%
Partial Response
17%
Complete Response
17%
Thrombocytopenia
17%
Neurotoxicity
15%
Pharmacovigilance System
14%
Teaching Hospital
14%
Clinical Evidence
13%
Hospital Physicians
13%
Feedback Sessions
12%
Physician Opinion
12%
Educational Activities
12%
Medical Specialities
11%
Patient Characteristics
10%
Adverse Effects
8%
Clinical Response
8%
Cutaneous Lupus Erythematosus
8%
Neurological Manifestations
8%
SLE Disease Activity Index (SLEDAI)
8%
Joint Involvement
8%
Clinical Characteristics
8%
Clinical Judgment
7%
Relevant Changes
7%
Behavioral Disorders
7%
Hypoalbuminemia
7%
Renal Function
7%
Pharmacokinetic Properties
7%
Carbapenems
7%
Inappropriate Treatment
7%
Renal Failure
7%
Fatal Outcome
7%
Pharmacodynamic Properties
7%
Patient Prognosis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Drug Reaction
100%
Off-Label Use
62%
Retrospective Study
62%
Pharmacovigilance
55%
Rituximab
41%
Systemic Lupus Erythematosus
31%
Disease Activity
31%
Ertapenem
31%
Prospective Study
31%
Disease
31%
Confusion
31%
Adverse Event
25%
Creatinine
23%
Thrombocytopenia
17%
Neurotoxicity
15%
Prospective Cohort Study
10%
Clinical Trial
10%
Omalizumab
10%
Clostridium Botulinum Type A
10%
Remission
8%
Diarrhea
7%
Pharmacokinetics
7%
Carbapenem
7%
Hypoalbuminemia
7%
Fatality
7%
Pharmacodynamics
7%
Moderate Renal Impairment
7%
Behavior Disorder
7%
Pharmacotherapy
6%
Drug Toxicity
6%
Medicine and Dentistry
Human Immunoglobulin
31%
Immunoglobulin
31%
Adverse Drug Reaction
31%
Hospital
31%
Patient
24%
Health Care Cost
13%
Immune Deficiency
6%